chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.83
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Convulsion, Full blood count, Influenza virus test
Clinical narrative: Ftr stated that child had seizure 2-2 1/2 hrs after vaccine given. Pt was brought by ambulance to Emergency Room. Pt recovered.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Episode of zoster approx 1-2 days post vaccine.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Chills, Erythema, Pruritus, Rash generalised, Rash maculo-papular
Clinical narrative: Grandmother called and spoke to doctor and states pt awoke with rash from head to toe, positive itching and feels chilled. Grandmother denies SOB and throat swelling. Also, states coughing but feels pt had cough previous. Pt saw Dr. on 03/04/2011. Dr. noted macular papular erythema on face, trunk and extremities. Dr. gave pt Benadryl.
Age: 80.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Myalgia, Pain, Pyrexia, Vaccination complication
Clinical narrative: "Fever, chills, and pain 11/10". Pt was admitted 2/3/11 to Hospital and hospitalized x 7 days.  Pt states currently on prednisone 25mg and titrating. Pt states was dx with myalgia due to vaccine.
Age: 80.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Myalgia, Pain, Pyrexia
Clinical narrative: "Fever, chills, and pain 11/10". Pt was admitted 2/3/11 to Hospital and hospitalized x 7 days.  Pt states currently on prednisone 25mg and titrating. Pt states was dx with myalgia due to vaccine.
Age: 53.0
Sex: M
Vaccine: TD
Symptoms: Mental status changes
Clinical narrative: Patient complained of altered mental status after vaccination.
Age: 51.0
Sex: F
Vaccine: TD, TD
Symptoms: Injection site nodule, Injection site oedema, Injection site pain, Nuclear magnetic resonance imaging normal, Oedema peripheral
Clinical narrative: Pt c/o knot to left deltoid after receiving tetanus shot. Since then has been complaining of pain and edema in left arm. Patient has had an MRI and U/S of arm with no significant findings.
Age: 51.0
Sex: F
Vaccine: TD, TD
Symptoms: Pain in extremity, Red blood cell sedimentation rate increased, Ultrasound scan normal
Clinical narrative: Pt c/o knot to left deltoid after receiving tetanus shot. Since then has been complaining of pain and edema in left arm. Patient has had an MRI and U/S of arm with no significant findings.
Age: 51.0
Sex: F
Vaccine: TD, TD
Symptoms: Axillary pain, Breast pain, Hypoaesthesia, Injected limb mobility decreased, Injection site erythema
Clinical narrative: Pt c/o knot to left deltoid after receiving tetanus shot. Since then has been complaining of pain and edema in left arm. Patient has had an MRI and U/S of arm with no significant findings.
Age: 51.0
Sex: F
Vaccine: TD, TD
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling, Oedema peripheral
Clinical narrative: Pt c/o knot to left deltoid after receiving tetanus shot. Since then has been complaining of pain and edema in left arm. Patient has had an MRI and U/S of arm with no significant findings.
Age: 51.0
Sex: F
Vaccine: TD, TD
Symptoms: Pain, Pain in extremity, Tenderness
Clinical narrative: Pt c/o knot to left deltoid after receiving tetanus shot. Since then has been complaining of pain and edema in left arm. Patient has had an MRI and U/S of arm with no significant findings.
Age: 19.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Dizziness, Erythema, Nausea, Oedema peripheral
Clinical narrative: 1:00pm 4-28-11 pt. states had onset of nausea and dizziness. Also, 4th finger (pointer finger) with redness and swelling. Then 7:30pm on 4-28-11 noted redness and swelling of 1st finger (pinky finger). 4-29-11 9:15AM nausea, dizziness resolved. States swelling & redness decreased to 1st & 4th finger.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Full blood count normal, Injection site pain, Pain, Red blood cell sedimentation rate normal, X-ray normal
Clinical narrative: April 21st -> Tdap vaccine administered, pt describes painful administration of vaccine. Pt given 400mg Ibuprofen, sore all day April 22nd -> pt returns to clinic due to pain "severe". Ice, Ibuprofen April 24th -> pt began doing warm compresses. April 26th -> pt went back to work. Pain was not as severe but present. April 27th -> severe pain returned. April 29th -> pt  returned to clinic, pt given Ibuprofen, x-ray, exam, sed rate, CBC, sling given. Referral to PT -> vaccine inj site -> no swelling, no itching, no heat, no numbness, no weakness.
Age: 11.0
Sex: M
Vaccine: HEP, IPV, TDAP, VARCEL
Symptoms: Rash
Clinical narrative: Patient had a rash on his chest & arm on 4/27/11.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site warmth, Local reaction
Clinical narrative: Large local reaction noted in upper arm. Area size of softball/baseball. Area hard & red & warm to touch. Left arm.
Age: 5.0
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: (R) arm with large area of redness, swelling & warmth to touch. Area size about baseball size.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV1
Symptoms: Haematochezia
Clinical narrative: Streaking blood in stool 1 day after administration of ROTARIX vaccine.
Age: 15.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Disorientation, Dyspnoea, Gait disturbance, Headache, Local swelling
Clinical narrative: 24 hrs after vaccines developed fever, arm pain & local swelling, then generalized rash (not hives), shortness of breath, wheezing. Also was unsteady when walking, disoriented, had a severe headache and neck pain. Nebulizer at home & dose of BENADRYL helped. Still not back to herself as of 48 hrs (24 hrs after symptoms) but improving. Mom feels she is acting mildly disoriented.
Age: 15.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Neck pain, Pain in extremity, Pyrexia, Rash generalised, Wheezing
Clinical narrative: 24 hrs after vaccines developed fever, arm pain & local swelling, then generalized rash (not hives), shortness of breath, wheezing. Also was unsteady when walking, disoriented, had a severe headache and neck pain. Nebulizer at home & dose of BENADRYL helped. Still not back to herself as of 48 hrs (24 hrs after symptoms) but improving. Mom feels she is acting mildly disoriented.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Skin lesion
Clinical narrative: Approx 1 1/2 inch by 1 1/2 inch erythematous warm, tender lesion to (R) arm at injection site.
Age: 21.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site discolouration, Injection site pain, Injection site reaction
Clinical narrative: Nickel size purple indentation (L) deltoid associated at times with pain (L) deltoid. T-97.5.
Age: 46.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Unevaluable event
Clinical narrative: Patient is a 46-year-old female, yesterday she had a DPT and a PNEUMOVAX.  In the arm in which she had the DPT the right shoulder, there is erythema, warmth, a large knot.  Patient developed fevers.  Tonight she came into the emergency room and her temperature was 101.5, earlier she says that it was 103.  She also was severely hypertensive with a blood pressure of 191/100, pulse 152, respiratory rate 24, all consistent with sepsis.  Patient's blood work reinforced this with a lactic acid level of 3.47, white count of 18,8 with 88% neutrophils.  She also had an elevated sugar on the Chem-12 of 148.  Urinalysis was negative.  Lactic acid, I think was mentioned above, 3.47.
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site swelling
Clinical narrative: Redness, swelling at injection site.
Age: 1.52
Sex: F
Vaccine: MMR
Symptoms: Eye discharge, Otorrhoea, Pyrexia, Rash generalised, Rhinorrhoea
Clinical narrative: Initial adverse event was yellow mucus in eyes and wet fluid coming out of right ear. After symptoms subsided, child broke out in hives rash all over body with fever and yellow mucus from nose. Child still has not recovered.
Age: 1.52
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Initial adverse event was yellow mucus in eyes and wet fluid coming out of right ear. After symptoms subsided, child broke out in hives rash all over body with fever and yellow mucus from nose. Child still has not recovered.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Chest X-ray normal, Chest pain, Full blood count abnormal, Injection site pain, Pain
Clinical narrative: Information has been received from a health care worker concerning a 52 year old female patient with asthma, latex allergy, IVP dye allergy and "kitten triggers her allergies", who on 08-APR-2011 was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (lot# 667913/1021Z, expiration date 27-FEB-2012) intramuscularly into her left deltoid.  Concomitant therapy included PROAIR.  On 08-APR-2011, minutes post vaccination the patient experienced achiness and pain in left arm that increased in intensity later on in the evening.  It was reported that the pain was in the upper left arm and then the patient developed pain in her anterior chest.  The patient called the doctor office the next morning on 09-APR-2011 at 7:30 AM, and the service suggested she go to the emergency room, which she did.  The patient had been seen at emergency room where several tests were performed: chest X-ray normal, CBC with white blood count at 11.3 and Troponin test normal.  The patient's pain level, on scale of 1 to 10 with one being the lowest, was 8 for her arm and 5 for her chest.  The patient was treated with TORADOL and MOTRIN 600 mg every 6 to 8 hours and was released without hospitalized.  The patient called her doctor's office on 22-APR-2011 to let them know now she was no more symptoms.  All events were considered to be other important medical events by the reporter.  Additional information has been requested.  The patient had been seen at hospital ER where several tests were performed.
Age: 52.0
Sex: F
Vaccine: PPV
Symptoms: Troponin, White blood cell count increased
Clinical narrative: Information has been received from a health care worker concerning a 52 year old female patient with asthma, latex allergy, IVP dye allergy and "kitten triggers her allergies", who on 08-APR-2011 was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (lot# 667913/1021Z, expiration date 27-FEB-2012) intramuscularly into her left deltoid.  Concomitant therapy included PROAIR.  On 08-APR-2011, minutes post vaccination the patient experienced achiness and pain in left arm that increased in intensity later on in the evening.  It was reported that the pain was in the upper left arm and then the patient developed pain in her anterior chest.  The patient called the doctor office the next morning on 09-APR-2011 at 7:30 AM, and the service suggested she go to the emergency room, which she did.  The patient had been seen at emergency room where several tests were performed: chest X-ray normal, CBC with white blood count at 11.3 and Troponin test normal.  The patient's pain level, on scale of 1 to 10 with one being the lowest, was 8 for her arm and 5 for her chest.  The patient was treated with TORADOL and MOTRIN 600 mg every 6 to 8 hours and was released without hospitalized.  The patient called her doctor's office on 22-APR-2011 to let them know now she was no more symptoms.  All events were considered to be other important medical events by the reporter.  Additional information has been requested.  The patient had been seen at hospital ER where several tests were performed.
Age: 25.0
Sex: M
Vaccine: HEPA
Symptoms: Headache, Injection site pain, Somnolence
Clinical narrative: Injection site pain and drowsiness was noted throughout the day. Moderate and continuous headache around the temple, use of ibuprofen offered minor benefit.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Abortion spontaneous, Drug exposure during pregnancy
Clinical narrative: 11 weeks pregnant and vaccinated with H1N1 on Thursday, 1/27/11.  Showed signs of miscarriage on Sunday, 1/30/11.  Miscarriage confirmed 2/1/11.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Injected limb mobility decreased, Injection site swelling
Clinical narrative: Swelling at Immunization site since given 4/4/11. Sometimes as large as an egg. Swelling typically goes down inthe pm and recurrs during the daytime. Inability to lift arm above 45 degree angle. These signs and symptoms reported to provider by patient.
Age: 16.0
Sex: F
Vaccine: FLU3, HEPA, HPV4, MNQ
Symptoms: Dizziness, Pallor
Clinical narrative: 4:45PM. Pt. face color pale and dizziness after vaccines. 1650 v/s B/P-82/46 HR-60 - R-20. Pt drank cold water/orange juice. Pt. placed on table in lying down, on back with legs up. 4:54. v/s 97/51-59-20. 5:00PM - Pt. face color pink, states, feeling better. No dizziness. Pt. resting on chair. 5:17 v/s 93/53-56-20. 5:45PM. Pt. stable condition and accompany with parents.
Age: 19.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Injection site rash, Rash maculo-papular
Clinical narrative: Client reports noticed rash on 4-24-11 involving Left deltoid area. Presented at Health Clinic on 4-26-11 with localized and well-defined macular, papular rash over Left deltoid area. Denies any shortness of breath, wheezing, or sore throat. Client stated she thought that she received Meningitis vaccination in Left arm and 3rd HPV in Right arm; call to Clinic-Medical Records and nurse unable to verify administration sites. Later received call from clinic nurse stating HPV given in Left deltoid and Meningitis given in Right deltoid. Client will take CLARITIN tonight and continue x 3-4 days and take BENADRYL 25-50 mg po q 4-6 hours prn. Status check 4-27-11: Symptoms no worse, still has rash, will call if not resolving.
Age: 5.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Injection site discolouration, Injection site erythema, Injection site haematoma, Injection site nodule, Injection site urticaria
Clinical narrative: (L) leg knot on leg at injection site, welt looks like a goose egg, reddened, bruised purplish, blue.
Age: 2.0
Sex: F
Vaccine: HEPA, PNC13
Symptoms: Injection site cellulitis, Injection site swelling
Clinical narrative: LEFT THIGH SWELLING TREATED WITH ANTIBIOTICS FOR CELLULITIS
Age: 26.0
Sex: F
Vaccine: DTAP
Symptoms: Headache, Heart rate increased, Injection site pain, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: I first experienced soreness at the site, a headache that was supposed to last at least two days. However, it progressed during that week for longer than two days. Then, I had experienced stiffness in my neck for about four days after the first symptoms and the continued headaches and soreness in both arms and I did my measurements and realized I lost nine pounds of muscle. I continue to have stiffness in my neck as well as the headaches appear off and on after three weeks of having the shot. I also experienced increased heart rate the first five days after I received the shot.
Age: 26.0
Sex: F
Vaccine: DTAP
Symptoms: Weight decreased
Clinical narrative: I first experienced soreness at the site, a headache that was supposed to last at least two days. However, it progressed during that week for longer than two days. Then, I had experienced stiffness in my neck for about four days after the first symptoms and the continued headaches and soreness in both arms and I did my measurements and realized I lost nine pounds of muscle. I continue to have stiffness in my neck as well as the headaches appear off and on after three weeks of having the shot. I also experienced increased heart rate the first five days after I received the shot.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Amblyopia, Eye irritation, Eye pruritus, Eye swelling, Lip swelling
Clinical narrative: Start: lazy eye (right side) Next day:  itchy, swollen eye (right side) Yesterday:  Irritation, swelling itchy eye (right side) Today:  right eye, swollen, Lips swollen
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Similar reaction on previous exposure to drug
Clinical narrative: Start: lazy eye (right side) Next day:  itchy, swollen eye (right side) Yesterday:  Irritation, swelling itchy eye (right side) Today:  right eye, swollen, Lips swollen
Age: 11.0
Sex: F
Vaccine: FLU3, HEPA, MNQ, TDAP
Symptoms: Electromyogram normal, Injection site anaesthesia
Clinical narrative: Numbness reported in bilateral, posterior upper arms where immunizations (Right Arm- Hep A, Tdap;  Left Arm- Influenza TIV, Menactra) were given. Numbess reported to begin about 1 day after vaccines were given.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site inflammation, Injection site pruritus, Injection site swelling
Clinical narrative: Swollen, inflammed, itchy area left deltoid.  Size 5 inches by 5 inches in size.
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Left deltoid slightly swollen, hot to touch, slight bump.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Blister, Cellulitis, Skin warm
Clinical narrative: Pt received DTAP on 4/25/11. On 4/26/11 developed rash like blisters around area. On 4/28/11 cellulitis the size of saucer, warm - no fever.
Age: 10.0
Sex: F
Vaccine: MMR, PNC13, VARCEL
Symptoms: Parotitis, Swelling face
Clinical narrative: (L) cheek swelling bgan 4/28. See in office 4/29 - consistent with mild parotitis. Afebrile & well appearing. Suspect mumps component of MMR vaccine was the culprit.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Musculoskeletal pain
Clinical narrative: Persistent shoulder pain with weakness, persistent massage and physical therapy pending as of 4/29/2011
Age: 20.0
Sex: F
Vaccine: YF
Symptoms: Blister, Scratch
Clinical narrative: SCRATCHY PATCHES AND BLISTERS ON MY INNER ARM NEXT TO THE INJECTION SITE.
Age: 52.0
Sex: F
Vaccine: FLUX, HEPAB, TTOX
Symptoms: Activities of daily living impaired, Arthralgia, Body temperature decreased, Cough, Influenza
Clinical narrative: SORE THROAT, COUGHING AND OVER ALL BODY PAINS, AND BELOW NORMAL TEMPERATURE. SHE WENT TO THE DOCTOR AND HE SAID IT WAS THE FLU. WITH TIME THE PAINS CONTINUED SHE WENT TO THE EMERGENCY ROOM AND THE DOCTOR SAID IT POSSIBLE THAT IT WAS AN ADVERSE REACTION TO THE 5 VACCINATIONS RECEIVED. HE RECOMMENDED REST AND SAID THAT WITHIN TWO WEEKS SHE SHOULD BE FINE. HOWEVER MORE THAN A MONTH AND EACH DAY SHE FEELS WORSE. SHE HAS SEVERE PAIN IN THE ARTICULATIONS, THAT MAKE IT VERY DIFFICULT TO PERFORM DAILY TASKS SUCH AS BATHING, DRESSING, EATING, ETC. I HAVE TAKEN HER TO AN ENDROCRINOLOGIST AND THEY PERFORMED MANY LAB TESTS ALL HAVE RESULTED OK AND THE DOCTOR HAS NO IDEA WHY SHE CONTINUES FEELING SO BAD.
Age: 52.0
Sex: F
Vaccine: FLUX, HEPAB, TTOX
Symptoms: Laboratory test normal, Oropharyngeal pain, Pain
Clinical narrative: SORE THROAT, COUGHING AND OVER ALL BODY PAINS, AND BELOW NORMAL TEMPERATURE. SHE WENT TO THE DOCTOR AND HE SAID IT WAS THE FLU. WITH TIME THE PAINS CONTINUED SHE WENT TO THE EMERGENCY ROOM AND THE DOCTOR SAID IT POSSIBLE THAT IT WAS AN ADVERSE REACTION TO THE 5 VACCINATIONS RECEIVED. HE RECOMMENDED REST AND SAID THAT WITHIN TWO WEEKS SHE SHOULD BE FINE. HOWEVER MORE THAN A MONTH AND EACH DAY SHE FEELS WORSE. SHE HAS SEVERE PAIN IN THE ARTICULATIONS, THAT MAKE IT VERY DIFFICULT TO PERFORM DAILY TASKS SUCH AS BATHING, DRESSING, EATING, ETC. I HAVE TAKEN HER TO AN ENDROCRINOLOGIST AND THEY PERFORMED MANY LAB TESTS ALL HAVE RESULTED OK AND THE DOCTOR HAS NO IDEA WHY SHE CONTINUES FEELING SO BAD.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: C-reactive protein, Crying, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: Patient had his shots that afternoon, slept for a little while, then woke up crying changed his diaper and was holding him and he went very white, limp, and unresponsive. We took him to the ER on the way was trying to get him to move and wake up, appeared to not be breathing, was very pale in color. Once in the ER started to move one arm a little still very pale. Was tranferred to another hospital by ambulance and had a series of tests done and stayed for two days. Was put on an apnea monitor and sent home.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Electroencephalogram, Full blood count, Hypotonia, Metabolic function test, Pallor
Clinical narrative: Patient had his shots that afternoon, slept for a little while, then woke up crying changed his diaper and was holding him and he went very white, limp, and unresponsive. We took him to the ER on the way was trying to get him to move and wake up, appeared to not be breathing, was very pale in color. Once in the ER started to move one arm a little still very pale. Was tranferred to another hospital by ambulance and had a series of tests done and stayed for two days. Was put on an apnea monitor and sent home.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Unresponsive to stimuli, X-ray gastrointestinal tract
Clinical narrative: Patient had his shots that afternoon, slept for a little while, then woke up crying changed his diaper and was holding him and he went very white, limp, and unresponsive. We took him to the ER on the way was trying to get him to move and wake up, appeared to not be breathing, was very pale in color. Once in the ER started to move one arm a little still very pale. Was tranferred to another hospital by ambulance and had a series of tests done and stayed for two days. Was put on an apnea monitor and sent home.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Activated partial thromboplastin time shortened, Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: Bruising, petechiae. Seen in ED 2/13 and thrombocytopenic on labs. Platelet count of 2 (10E9/L). Diagnosed with idiopathic thrombocytopenic purpura. No hospitalization or treatment. Platelet counts followed intermittently per hematology recommendations from 2/19 to 4/2 at which time platelet count resolved independently. Never needed to see hematology. Followed by PCP.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine increased, Blood glucose normal
Clinical narrative: Bruising, petechiae. Seen in ED 2/13 and thrombocytopenic on labs. Platelet count of 2 (10E9/L). Diagnosed with idiopathic thrombocytopenic purpura. No hospitalization or treatment. Platelet counts followed intermittently per hematology recommendations from 2/19 to 4/2 at which time platelet count resolved independently. Never needed to see hematology. Followed by PCP.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Blood potassium decreased, Blood smear test normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal
Clinical narrative: Bruising, petechiae. Seen in ED 2/13 and thrombocytopenic on labs. Platelet count of 2 (10E9/L). Diagnosed with idiopathic thrombocytopenic purpura. No hospitalization or treatment. Platelet counts followed intermittently per hematology recommendations from 2/19 to 4/2 at which time platelet count resolved independently. Never needed to see hematology. Followed by PCP.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Contusion, Globulin, Idiopathic thrombocytopenic purpura, International normalised ratio normal, Petechiae
Clinical narrative: Bruising, petechiae. Seen in ED 2/13 and thrombocytopenic on labs. Platelet count of 2 (10E9/L). Diagnosed with idiopathic thrombocytopenic purpura. No hospitalization or treatment. Platelet counts followed intermittently per hematology recommendations from 2/19 to 4/2 at which time platelet count resolved independently. Never needed to see hematology. Followed by PCP.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Platelet count decreased, Protein total normal, Prothrombin time normal, Thrombocytopenia
Clinical narrative: Bruising, petechiae. Seen in ED 2/13 and thrombocytopenic on labs. Platelet count of 2 (10E9/L). Diagnosed with idiopathic thrombocytopenic purpura. No hospitalization or treatment. Platelet counts followed intermittently per hematology recommendations from 2/19 to 4/2 at which time platelet count resolved independently. Never needed to see hematology. Followed by PCP.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Abnormal behaviour, Confusional state, Depression, Diarrhoea, Headache
Clinical narrative: Within 48 hours of TDAP, complained of site pain, HA, trouble sleeping. 4/2/11 experienced confusion, sinus & inner ear trouble while flying, hospitalized on 4-3-11 for increased confusion and behavioral changes. Became unresponsive but remained conscious. Flew home with (Info provided by mother of client) assistance.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Inner ear disorder, Insomnia, Oral herpes, Sinus disorder
Clinical narrative: Within 48 hours of TDAP, complained of site pain, HA, trouble sleeping. 4/2/11 experienced confusion, sinus & inner ear trouble while flying, hospitalized on 4-3-11 for increased confusion and behavioral changes. Became unresponsive but remained conscious. Flew home with (Info provided by mother of client) assistance.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Unresponsive to stimuli, Urinary incontinence
Clinical narrative: Within 48 hours of TDAP, complained of site pain, HA, trouble sleeping. 4/2/11 experienced confusion, sinus & inner ear trouble while flying, hospitalized on 4-3-11 for increased confusion and behavioral changes. Became unresponsive but remained conscious. Flew home with (Info provided by mother of client) assistance.
Age: 0.31
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Barium double contrast, Enema administration, Intussusception, Surgery, Ultrasound abdomen
Clinical narrative: 4 days after receiving delays 2 mo vaccines, including ROTARIX, pt developed intussusception that needed to be surgically reduced. (DTap-HBV-POL, HIB, PCV 13, ROT 1).
Age: 33.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug exposure during pregnancy
Clinical narrative: Mistakenly gave Varicella vaccine to a pregnant woman 16 weeks pregnant.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: After 8-12 hours since injection a low grade fever 99-100 degrees began along with chills and aches in neck and back, body aches.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Body temperature increased, Pain, Swelling
Clinical narrative: Pt reports pain & swelling under Rt arm near breast temp 102. 4/27 feels better now. Declines ov or further treatment will call if needed for follow up.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Erythema, Hypotonia, Injection site warmth, Pyrexia
Clinical narrative: Fever, redness, limp, site warm. Rx antibiotic - KEFLEX oral on 4/29/11.
Age: 30.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Within one hour post vaccination with AVA #1, and his third typhoid on 23 Feb 11, he began to experience fatigue, and chills. Later that evening he developed a fever with worsening of fatigue and chills, followed by headache and myalgias. The fever lasted 3-4 days with myalgias subsiding during the second week.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site pain, Oedema peripheral
Clinical narrative: Pt's. mom states pt. arm is swelling and c/o pain injection site times 2 days.
Age: 56.0
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Musculoskeletal stiffness, Palpitations
Clinical narrative: 03/25/11 - Several hours after receiving MMR - heart racing stiff neck stiff feet. Went to ER - Rx VALIUM & Ibuprofen. Cont with stiff neck, general weakness. Seen by cardiologist - heart O.K. Still having general weakness 4/13/11 - was seeing her doctor again.
Age: 0.2
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13
Symptoms: Injection site urticaria, Livedo reticularis, Skin lesion, Urticaria
Clinical narrative: Within 1-2 minutes of receipt of his immunizations patient exhibited a pattern of cutis marmorata involving all extremities, as well as several (half dozen) small urticarial lesions located over the lower legs and ankles and over the upper chest and back and one or two over the extremities. No treatment was given. The lesions disappeared within 20 minutes.
Age: 61.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: (R) sided neck pain & stiffness - mild injection site soreness - Tx with ZANAFLEX. F/U Tx to pt reveals he has had reaction to Thimerosal in past from eye drops. Allergy list updated.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site discomfort, Injection site swelling
Clinical narrative: Varicella #2 given per order of travel MD. Returned in 2 days with swelling & discomfort at injection site. No temperature. No signs of infection at this time. Seen by Dr.
Age: 0.53
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Muscle twitching, Pyrexia
Clinical narrative: Fever with 102, flinching.
Age: 54.0
Sex: F
Vaccine: DT
Symptoms: Drug administered at inappropriate site, Injection site nodule, Injection site pain
Clinical narrative: Initial case received from a health care professional on 07 June 2010. It involves a case of "vaccine administered at inappropriate site". A 54-year-old female patient received an intramuscular gluteal injection of DECAVAC (lot number U2972AA) on 26 May 2010. The patient had a history of a "dirty wound", and was given 1 gram of ANCEF concomitantly; she also had a history of anxiety. On 27 May 2010 the patient complained of tenderness and a knot at the site. At the time of the report, the patient was scheduled to see a physician. The events remained ongoing. Of note, the preferred administration site for DECAVAC is the deltoid muscle; it is recommended that DECAVAC not be administered in the gluteal muscle. Follow-up information was received from a health care professional on 30 July 2010. The patient was seen in the clinic on 16 June 2010 "no sequelae" was noted from the knot at the previous injection site on the buttocks. The patient's hand wound had also resolved and she was revaccinated in the left deltoid with DECAVAC (lot number U2972AA and route of administration not reported). No further information was available at time of this report. Document held by sender: none.
Age: 65.0
Sex: F
Vaccine: DT
Symptoms: Muscle tightness
Clinical narrative: Initial report received from a physician on 18 August 2010. A 65-year-old female patient had received an intramuscular left deltoid booster injection of DECAVAC (lot number U3073BA) on 17 August 2010. By 19:30 that night she had tightness in the right and left jaw that persists at 75 percent tightness. The patient was treated with BENADRYL with some improvement. It was reported the patient had no concurrent illnesses and no known allergies at the time of the vaccination. She had not received any other vaccinations within 4 weeks prior to 17 August 2010. The patient currently takes ARMOUR THYROID (indication not reported). At the time of this report, the patient had not recovered. Follow-up information was received from a health care professional on 12 November 2010. The patient has a past medical history of "hypothyroid". No further information was available at the time of the report. The patient's outcome was reported as recovered on 24 August 2010. Documents held by sender: None.
Age: 30.0
Sex: M
Vaccine: DT
Symptoms: Erythema, Induration, Pruritus, Skin warm, Wrong drug administered
Clinical narrative: Case report received from a healthcare professional on 08 October 2010 under the reference number 10-0688. A 30-year-old male patient with no reported medical history had received an intradermal dose of DECAVAC (batch number unknown) in the arm (side unknown) instead of TUBERSOL on 06 October 2010. The patient had a concomitant treatment with LORCET prn for back pain. In October 2010 (exact date not reported), the patient presented with red, hot and hard area on arm, with slight itching. The patient required doctor visit. At the time of the report, the patient had not recovered. List of Documents held by sender: none.
Age: 65.0
Sex: F
Vaccine: DT
Symptoms: Local reaction
Clinical narrative: Initial report received from a health care professional on 05 November 2010. A 65-year-old female patient, with a history of increase blood pressure and increased lipids, received in July 2009 an intramuscular injection (site not reported) of DECAVAC, lot number U2024AA. The patient had no known allergies and no illness at the time of vaccination. Her concomitant medications were not reported. The patient developed on an unknown date a large local reaction. The patient had a similar reaction to a flu shot last year (manufacturer unknown). No further information was available as to the type of reaction. The outcome was not reported. Documents held by sender: None.
Age: 26.0
Sex: F
Vaccine: DT
Symptoms: Injection site erythema, Injection site irritation, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: Initial case received from a nurse on 17 November 2010. It involves a case of misuse, i.e. wrong vaccine administered. This case pertains to  1 of a cluster of 5 patients who experienced adverse events following intradermal administration of DECAVAC. A 26-year-old female patient received an intradermal right forearm injection of DECAVAC (lot number U3422DA) on 16 November 2010. Medical history included allergies to BACTRIM and Sulfa, and concomitant medications included PROVERA and VIVELLE-DOT. The day of vaccination, the patient experienced irritation at the injection site described as a 3 cm x 4 cm area that was red, raised, and painful. Additionally, the patient complained of pain "running up the arm, and the arm is painful to touch". Outcome was not reported. Information for the other patients is captured in case numbers 2010-06503, 2010-06506, and 2010-06508.
Age: 26.0
Sex: F
Vaccine: DT
Symptoms: Wrong drug administered
Clinical narrative: Initial case received from a nurse on 17 November 2010. It involves a case of misuse, i.e. wrong vaccine administered. This case pertains to  1 of a cluster of 5 patients who experienced adverse events following intradermal administration of DECAVAC. A 26-year-old female patient received an intradermal right forearm injection of DECAVAC (lot number U3422DA) on 16 November 2010. Medical history included allergies to BACTRIM and Sulfa, and concomitant medications included PROVERA and VIVELLE-DOT. The day of vaccination, the patient experienced irritation at the injection site described as a 3 cm x 4 cm area that was red, raised, and painful. Additionally, the patient complained of pain "running up the arm, and the arm is painful to touch". Outcome was not reported. Information for the other patients is captured in case numbers 2010-06503, 2010-06506, and 2010-06508.
Age: 32.0
Sex: F
Vaccine: DT
Symptoms: Drug exposure during pregnancy, Erythema, Feeling abnormal, Injection site erythema, Vaccination site swelling
Clinical narrative: Initial case received from a nurse on 17 November 2010. This involves a case of misuse, i.e. wrong vaccine administered; it is also a pregnancy case. The patient is 1 of a cluster of 5 patients who experienced adverse events following intradermal administration of DECAVAC. A 32-year-old pregnant female patient received a left forearm intradermal injection of DECAVAC (lot number U3422DA) instead of TUBERSOL 5TU on 16 November 2010. The patient was 11 weeks pregnant at the time of vaccination, and medical history included CIPRO allergy. She had a history of 2 previous miscarriages. Following vaccination, the patient developed a 6 cm x 7 cm area around the vaccination site which was red, hot, and raised. She also complained of a 6 cm x 7 cm lighter red streak going up the arm towards the elbow, and noted that her left 5th finger "feels like it wants to contract". She was not taking any medications, and was not ill at the time of vaccination. The event was ongoing at the time of the report. The events for the other patients in this cluster are captured in case numbers 2010-06503, 2010-03604, and 2010-03608.
Age: 32.0
Sex: F
Vaccine: DT
Symptoms: Vaccination site warmth, Wrong drug administered
Clinical narrative: Initial case received from a nurse on 17 November 2010. This involves a case of misuse, i.e. wrong vaccine administered; it is also a pregnancy case. The patient is 1 of a cluster of 5 patients who experienced adverse events following intradermal administration of DECAVAC. A 32-year-old pregnant female patient received a left forearm intradermal injection of DECAVAC (lot number U3422DA) instead of TUBERSOL 5TU on 16 November 2010. The patient was 11 weeks pregnant at the time of vaccination, and medical history included CIPRO allergy. She had a history of 2 previous miscarriages. Following vaccination, the patient developed a 6 cm x 7 cm area around the vaccination site which was red, hot, and raised. She also complained of a 6 cm x 7 cm lighter red streak going up the arm towards the elbow, and noted that her left 5th finger "feels like it wants to contract". She was not taking any medications, and was not ill at the time of vaccination. The event was ongoing at the time of the report. The events for the other patients in this cluster are captured in case numbers 2010-06503, 2010-03604, and 2010-03608.
Age: 52.0
Sex: M
Vaccine: DT
Symptoms: Psoriasis, Rash generalised, Skin exfoliation, Tinnitus
Clinical narrative: Initial report received from a health care professional on 07 February 2011. A 52-year-old male patient received on 27 July 2005 a right deltoid injection (route not provided) of DECAVAC, lot number U1217AA. The patient had no medical history but takes an unknown blood pressure medication. He had no illness at the time of vaccination and had no other vaccinations within 4 weeks of the DECAVAC. The patient went to the hospital for treatment for his high blood pressure and received DECAVAC as a booster. Six months later, his whole body broke out and he had ringing in his ears. He was seen by a health care professional and a dermatologist. Today he continues to have severe psoriasis with rash, scales, psoriasis all over legs, back and stomach. The outcome was reported as unknown. Documents held by sender: None.
Age: 45.0
Sex: F
Vaccine: DT
Symptoms: Dyspnoea
Clinical narrative: Initial report was received from a consumer on 14 February 2011 who is also the patient. A 45 year-old female patient who had no illness at the time of vaccination and has an allergy to thimerosal which was discovered after a "severe allergic reaction" following an Influenza vaccine 15 years ago, had received on 04 February 2011 an intramuscular left deltoid injection of DECAVAC (lot number not reported). On 08 February 2011, the patient reported she could not take a deep breath and felt like she could not catch her breath. The patient reported no chest or lung discomfort. She has not been evaluated by a physician. Treatments were not reported. The patient refused to provide names of concomitant medications. No further information was available at the time of the report. The patient's outcome was not recovered. The reporter for this case is the same as for case 2011-00629. Documents held by sender: none.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of swelling injection site in a 5-year-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-GSK); Merck; unknown; right arm given on 12 April 2011 at 10:00. Concurrent medications included Tuberculin given on 12 April 2011. On 12 April 2011 at 10:00 the subject received a dose of KINRIX (.5 unknown, unknown, left arm) as the 4th IPV and 5th PV in the series. On 13 April 2011 (during the night, in the early hours of the morning), 1 day after vaccination with KINRIX, the subject experienced swelling injection site and hotness at injection site of a 10-12 centimetre area. The events occurred in the same arm as KINRIX was given (left arm) and were described as a "severe injection site reaction". The subject was seen in the pediatrician's office on 13 April 2011 and was treated with Antibiotic. At the time of reporting the events were unresolved. The healthcare professional considered the events were probably related to vaccination with KINRIX.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and inflammation site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 1 of 7; see case IDs A0924036A-A0924041A for details of the other reports.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 2 of 7; see case IDs A0924034A, A0924037A-A0924041A for details of the other reports.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 3 of 7; see case IDs A0924034A, A0924036A, A0924038A-A0924041A for details of the other reports.
Sex: U
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 4 of 7; see case IDs A0924034A, A0924036A, A0924037A, A0924039A-A0924041A for details of the other reports.
Sex: U
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 5 of 7; see case IDs A0924034A, A0924036A-A0924038A, A0924040A, A0924041A for details of the other reports.
Sex: U
Vaccine: DTAPIPV
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 6 of 7; see case IDs A0924034A, A0924036A-A0924039A, A0924041A for details of the other reports.